Acasti Pharma, Inc. (ACST) Q1 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and welcome to the Ecosti Pharma first quarter fiscal year 2023 financial results conference call. All participants will be in listen-only mode. So if you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on a touch-tone phone. To withdraw your question, please press star then two. Please note, this event is being recorded. I would now like to turn the conference over to Robert Bloom with Lithum Partners. Please go ahead. Thank you very much, Rocco. Welcome to Akasi Pharma's first quarter fiscal 2023 conference call. On the call with us this afternoon is Jan Delvis, President and CEO. Brian Ford, Chief Financial Officer. Pierre Lemieux, Chief Operating and Scientific Officer. and Prashant Kohli, VP of Commercial Operations. Following management's prepared remarks, there will be a Q&A session. Should any questions remain after the call, please feel free to contact me at 602-889-9700. I'd also like to remind everyone that statements on this conference call that are not statements of historical or current facts constitute forward-looking information within the meaning of the Canadian securities laws and forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and the Securities in Exchange Act of 1934. Such forward-looking statements involve known and unknown risks and uncertainties that could cause the actual results to be materially different from those expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, listeners are urged to consider statements labeled wit...